AURA
Aura Biosciences Inc
NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY
$6.30
-1.64% today
Updated 2026-10-29
Market cap
$632.60M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.75
Dividend yield
—
52W range
$5 – $10
Volume
0.9M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-2.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$16.60
+163.70%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.05x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -2.58 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-31.82M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-58.76M | $-76.41M | $-86.92M | $-106.19M | $-45.64M |
| EPS | — | — | — | — | $-1.75 |
| Free cash flow | $-55.70M | $-64.56M | $-81.06M | $-85.19M | $-31.82M |
| Profit margin | — | — | — | — | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-09-01 | PERSON, JULIE | Buy | 212,389 | — |
| 2026-09-01 | PERSON, JULIE | Buy | 107,611 | — |
| 2026-09-01 | KRATZ, ERICA | Buy | 199,115 | — |
Peer comparison
Smart narrative
Aura Biosciences Inc trades at $6.30. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -2.58, it sits in the distress.
Frequently asked questions
What is Aura Biosciences Inc's stock price?
Aura Biosciences Inc (AURA) trades at $6.30.
Is Aura Biosciences Inc overvalued?
Aura Biosciences Inc carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Aura Biosciences Inc (AURA)?
The 12-month analyst consensus target is $16.60, about 163.7% above the current $6.30. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Aura Biosciences Inc's Altman Z-Score is -2.58, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-41.56%
Beta0.41
50D MA$6.98
200D MA$6.66
Shares out0.10B
Float0.07B
Short ratio—
Avg volume0.9M
Performance
1 week-5.79%
1 month+3.00%
3 months-12.34%
YTD+13.39%
1 year+1.31%
3 years—
5 years—